학술논문

Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
Document Type
article
Author
Helen BaldwinJoaquim RaduaMathilde AntoniadesShalaila S. HaasSophia FrangouIngrid AgartzPaul AllenOle A. AndreassenKimberley AtkinsonPeter BachmanInmaculada BaezaCali F. BartholomeuszMichael W. L. CheeTiziano ColibazziRebecca E. CooperCheryl M. CorcoranVanessa L. CropleyBjørn H. EbdrupAdriana ForteaLouise Birkedal GlenthøjHolly K. HamiltonKristen M. HautRebecca A. HayesYing HeKarsten HeekerenMichael KaessKiyoto KasaiNaoyuki KatagiriMinah KimJochen KindlerMallory J. KlaunigShinsuke KoikeAlex KoppelTina D. KristensenYoo Bin KwakJun Soo KwonStephen M. LawrieIrina LebedevaJimmy LeeAshleigh LinRachel L. LoewyDaniel H. MathalonChantal MichelRomina MizrahiPaul MøllerBarnaby NelsonTakahiro NemotoDorte NordholmMaria A. OmelchenkoChristos PantelisJayachandra M. RaghavaJan I. RøssbergWulf RösslerDean F. SalisburyDaiki SasabayashiUlrich SchallLukasz SmigielskiGisela SugranyesMichio SuzukiTsutomu TakahashiChristian K. TamnesJinsong TangAnastasia TheodoridouSophia I. ThomopoulosAlexander S. TomyshevPeter J. UhlhaasTor G. VærnesTherese A. M. J. van AmelsvoortTheo G. M. Van ErpJames A. WaltzLars T. WestlyeStephen J. WoodJuan H. ZhouPhilip McGuirePaul M. ThompsonMaria JalbrzikowskiDennis HernausPaolo Fusar-Polithe ENIGMA Clinical High Risk for Psychosis Working Group
Source
Translational Psychiatry, Vol 12, Iss 1, Pp 1-11 (2022)
Subject
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Language
English
ISSN
2158-3188
Abstract
Abstract Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profiles and outcome features. However, the extent of neuroanatomical heterogeneity in the CHR-P state is largely undetermined. We aimed to quantify the neuroanatomical heterogeneity in structural magnetic resonance imaging measures of cortical surface area (SA), cortical thickness (CT), subcortical volume (SV), and intracranial volume (ICV) in CHR-P individuals compared with healthy controls (HC), and in relation to subsequent transition to a first episode of psychosis. The ENIGMA CHR-P consortium applied a harmonised analysis to neuroimaging data across 29 international sites, including 1579 CHR-P individuals and 1243 HC, offering the largest pooled CHR-P neuroimaging dataset to date. Regional heterogeneity was indexed with the Variability Ratio (VR) and Coefficient of Variation (CV) ratio applied at the group level. Personalised estimates of heterogeneity of SA, CT and SV brain profiles were indexed with the novel Person-Based Similarity Index (PBSI), with two complementary applications. First, to assess the extent of within-diagnosis similarity or divergence of neuroanatomical profiles between individuals. Second, using a normative modelling approach, to assess the ‘normativeness’ of neuroanatomical profiles in individuals at CHR-P. CHR-P individuals demonstrated no greater regional heterogeneity after applying FDR corrections. However, PBSI scores indicated significantly greater neuroanatomical divergence in global SA, CT and SV profiles in CHR-P individuals compared with HC. Normative PBSI analysis identified 11 CHR-P individuals (0.70%) with marked deviation (>1.5 SD) in SA, 118 (7.47%) in CT and 161 (10.20%) in SV. Psychosis transition was not significantly associated with any measure of heterogeneity. Overall, our examination of neuroanatomical heterogeneity within the CHR-P state indicated greater divergence in neuroanatomical profiles at an individual level, irrespective of psychosis conversion. Further large-scale investigations are required of those who demonstrate marked deviation.